Predictors of low cardiac output syndrome after coronary artery bypass  by Rao, Vivek et al.
SURGERY FOR ACQUIRED 
HEART DISEASE 
PREDICTORS OF LOW CARDIAC OUTPUT SYNDROME AFTER CORONARY ARTERY BYPASS 
Vivek Rao, MD 
Joan Ivanov, RN, MSc 
Richard D. Weisel, MD 
John S. Ikonomidis, MD, PhD 
George T. Christakis, MD 
Tirone E. David, MD 
The purpose of this study was to identify patients at risk for the develop- 
ment of low cardiac output syndrome after coronary artery bypass. Low 
cardiac output syndrome was defined as the need for postoperative 
intraaortic balloon pump or inotropic support for longer than 30 minutes 
in the intensive care unit to maintain the systolic blood pressure greater 
than 90 mm Hg and the cardiac index greater than 2.2 L/min per square 
meter. The preoperative patient characteristics that were independent 
predictors of low cardiac output syndrome were identified among 4558 
consecutive patients who underwent isolated coronary artery bypass at The 
Toronto Hospital between July 1, 1990, and December 31, 1993. The overall 
prevalence of low cardiac output syndrome was 9.1% (n = 412). The 
operative mortality rate was higher in patients in whom low cardiac output 
syndrome developed than in those in whom it did not develop (16.9% versus 
0.9%, p < 0.001). Stepwise logistic regression analyses identified nine 
independent predictors of low output syndrome (percent frequency in 
parentheses) and calculated the factor-adjusted o ds ratios associated with 
each predictor: (1) left ventricular ejection fraction less than 20% (27%, 
odds ratio 5.7); (2) repeat operation (25%, odds ratio 4.4); (3) emergency 
operation (27%, odds ratio 3.7); (4) female gender (16%, odds ratio 2.5); (5) 
diabetes (13%, odds ratio 1.6); (6) age older than 70 years (13%, odds ratio 
1.5); (7) left main coronary artery stenosis (12%, odds ratio 1.4); (8) recent 
myocardial infarction (16%, odds ratio 1.4); and (9) triple-vessel disease 
(10%, odds ratio 1.3). Low cardiac output syndrome is a clinical outcome 
that may result from inadequate myocardial protection or perioperative 
ischemic injury. Patients at high risk for the development of low cardiac 
output syndrome should be the focus of trials of new techniques of 
myocardial protection to resuscitate the ischemic myocardium. (J Thorac 
Cardiovasc Surg 1996;112:38-51) 
T he contemporary results of coronary artery by- pass grafting are excellent. A recent review from 
our institution indicated that despite an increased 
frequency of high-risk patients, operative mortality 
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did not change. 1 Since that publication in 1989, the 
operative mortality rate after isolated coronary ar- 
tery bypass grafting at The Toronto Hospital has 
decreased to 2.4%; however, in higher risk groups 
the operative mortality rate is still two to four times 
greater. This study was intended to identify the 
independent predictors of low cardiac output syn- 
drome. We defined low cardiac output syndrome as 
the requirement for intraaortic balloon counterpul- 
sation or inotropic support for longer than 30 min- 
utes after the patient was returned to the intensive 
care unit to maintain the systolic blood pressure 
higher than 90 mm Hg and the cardiac index greater 
than 2.2 L/min per square meter. 
The development of low cardiac output syndrome 
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may represent a failure of myocardial protection or 
difficulty with bypass grafting and is often associated 
with a higher mortality and prolonged hospital stay. 
A recent randomized clinical trial done at the 
University of Toronto by The Warm Heart Investi- 
gators showed no difference in operative mortality 
or perioperative myocardial infarction (MI) be- 
tween patients who received warm blood or cold 
blood cardioplegic solution. 2However, the occurrence 
of low cardiac output syndrome was significantly lower 
in the warm group. Similarly, a large clinical trial that 
evaluated acadesine as a myocardial protective agent 
failed to show any difference in the prevalence of 
perioperative infarction except in a subgroup of pa- 
tients with high-risk conditions. 3 Because of the low 
rates of operative mortality and perioperative MI, 
studies aimed at developing improved strategies of 
myocardial protection are unlikely to show a benefit 
unless they include a large number of patients or limit 
their focus to subgroups of patients at high risk. Both 
operative mortality and a new perioperative MI occur 
infrequently and these outcome measures are difficult 
to use in a trial of alternate myocardial protective 
strategies even in patients at high risk. 
Low cardiac output syndrome is a more frequent 
event and may be modified by improved methods of 
myocardial protection in high-risk subgroups. How- 
ever, the syndrome must be carefully defined and its 
pathophysiologic components may be better under- 
stood by assessment of the predisposing risk factors. 
To make comparisons between studies, the defini- 
tion of low cardiac output syndrome must become 
standardized. This study presents the independent 
preoperative risk factors for the development of low 
cardiac output syndrome in 4558 consecutive pa- 
tients undergoing isolated coronary artery bypass 
grafting at The Toronto Hospital. 
Methods 
Patient population. Preoperative, perioperative, and 
postoperative data were collected prospectively on all 
patients undergoing isolated coronary artery bypass graft- 
ing between July 1, 1990, and December 31, 1993, at The 
Toronto Hospital. The preoperative characteristics of the 
4558 consecutive patients are shown in Table I. 
Operative technique. After median sternotomy and 
heparinization, cardiopulmonary b pass was established 
with a single two-stage right atrial cannula and an ascend- 
ing aortic cannula. During bypass, the hematocrit was 
maintained between 20% and 25%, pump flow rates 
between 2.0 and 2.5 L/min per square meter, and mean 
arterial pressures between 50 and 60 mm Hg by use of 
sodium nitroprusside or phenylephrine hydrochloride as 
required. In elderly patients or in patients with carotid 
Table I. Patient population 
N % 
N 4558 
Sex 
Male 3673 
Female 885 
Age (yr) 
Timing 
Elective 2620 
Semielective 1130 
Urgent 657 
Emergency 151 
Recent MI 692 
LVEF 
>60% 1530 
40%-60% 1926 
20%-40% 956 
<20% 146 
NYHA class 
I 76 
II 654 
III 1861 
IV 1967 
CAD 
] vessel 308 
2 vessel 1083 
3 vessel 3159 
Left main CAD 808 
Repeat operation 335 
Diabetes 1086 
Hypertension 2337 
PVD 591 
61.5 _+ 9.6 
81 
19 
57 
25 
14 
4 
15 
34 
42 
21 
3 
2 
14 
41 
43 
7 
24 
69 
18 
7 
24 
51 
13 
LVEF, Left ventricular ejection fraction; NYHA, New York Heart Asso- 
ciation; CAD, coronary artery disease; PVD, Peripheral vascular disease. 
artery stenoses, the mean arterial pressure was main- 
tained higher than 70 mm Hg in an attempt to improve 
cerebral perfusion. Blood cardioplegic solutions were 
delivered after oxygenated blood from the bypass circuit 
was mixed with a crystalloid solution in a 4:1 ratio. Blood 
cardioplegic solution was administered either in an ante- 
grade fashion via the aortic root or in a retrograde fashion 
via the coronary sinus. 
In all patients, the heart was arrested with an aortic root 
infusion of high potassium (27 mEq/L) blood cardioplegic 
solution. Cardioplegia was maintained with a low potas- 
sium formulation (15 mEq/L). Proximal and distal anas- 
tomoses were constructed during a single prolonged cross- 
clamp period. 4 A left internal thoracic artery graft was 
used in 3789 (83%) patients. Cardiac output was mea- 
sured with a thermodilution catheter placed percutane- 
ously via the internal jugular vein into the pulmonary 
artery. 5 
Patients in whom weaning from cardiopulmonary b - 
pass was ditficult or in whom inadequate cardiac perfor- 
mance developed in the intensive care unit had an in- 
traaortic balloon pump (Datascope Corporation, Paramus, 
N.J.) inserted percutaneously via thecommon femoral ar- 
tery. Patients with less severe hemodynamic compromise 
received inotropic medication. 
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Study design. This study represents a retrospective 
analysis on data gathered in a prospective fashion and 
included in a database registry. Multivariable analyses 
were used to determine the independent predictors of 
outcomes. Comparisons of baseline, operative, and post- 
operative data were made between patients in whom the 
outcome of interest occurred and patients in whom it did 
not. 
Definitions of variables. Appendix A gives a definition 
of all preoperative variables. 
Study outcomes. Low cardiac output syndrome was 
diagnosed if the patient required an intraaortic balloon 
pump either in the operating room or in the intensive care 
unit because of hemodynamic compromise. Patients who 
had a balloon pump inserted preoperatively because of 
either ischemic chest pain or hemodynamic dysfunction 
were believed to have a postoperative low cardiac output 
syndrome if, in addition to the balloon pump, they also 
required inotropic medication. Low cardiac output syn- 
drome was also diagnosed if the patient required inotropic 
medication to maintain the systolic blood pressure greater 
than 90 mm Hg and the cardiac output greater than 2.2 
L/rain per square meter for at least 30 minutes in the 
intensive care unit after correction of all electrolyte or 
blood gas abnormalities and after adjusting the preload to 
its optimal value. 6Afterload reduction was also attempted 
when possible. Patients received either dopamine hydro- 
chloride, dobutamine hydrochloride, amrinone, or epi- 
nephrine. We believe that prolonged treatment with ino- 
tropic medication may augment perioperative ischemic 
injury]' 8 Therefore inotropic medication was avoided 
when possible and was used only in patients who had mild 
and transient hemodynamic compromise. An intraaortic 
balloon pump was inserted in patients who had moderate 
or severe hemodynamic compromise. Patients who re- 
ceived less than 4 pg/kg of dopamine to increase renal 
perfusion were not considered to have low cardiac output 
syndrome. Patients who received vasoconstricting medica- 
tion because of a high cardiac output (->2.5 L/rain per 
square meter) and low peripheral resistance were not 
considered to have low cardiac output syndrome. 
Operative mortality and MI. Operative mortality was 
defined as any death that occurred within 30 days of 
operation or during the same hospital admission. A 
perioperative MI was documented when a new Q wave 
was found on the postoperative electrocardiogram. An MI 
was also diagnosed if the postoperative electrocardiogram 
had a new left bundle branch block, loss of R wave 
progression, or new ST and T wave changes if accompa- 
nied by a rise in the level of the MB isoenzyme of creatine 
kinase (CK-MB) greater than 50 U/L and if the CK- 
MB/CK ratio was greater than 5%. An antibody inhibition 
technique was used to measure the CK-MB level. The 
highest postoperative CK-MB value was recorded and 
expressed as a fraction of total CK if a perioperative 
ischemic event was suspected clinically. This definition of 
perioperative MI requires electrocardiographic changes 
and therefore may underestimate his outcome. 
Statistical analysis. Statistical analysis was done with 
the SAS program (SAS Institute, Cary, N.C.). Categorical 
data were analyzed by a )~2 or Fisher's exact test where 
appropriate. Continuous data were analyzed by two-tailed 
t tests. Logistic models for each outcome variable were 
constructed with the use of methods described by Hosmer 
and Lemeshow. 9 Each prognostic variable was carefully 
evaluated by the appropriate univariate test. Variables 
were selected for inclusion in a multivariable model if 
their univariatep value was less than 0.25 or if the variable 
was of known clinical importance but failed, univariately, 
to achieve the critical alpha level. 
Models were fit and the best model for each outcome 
variable was determined by (1) an examination of the 
Wald statistic for each variable 9 and (2) a comparison of 
each estimated coefficient with the coefficient from the 
univariate model that contained only that variable. Coef- 
ficients that changed markedly in magnitude indicated 
that one or more of the excluded variables were important 
in the adjustment of the effect of the remaining variables 
in the model and an effort was made to refit the model. 7
The next step in determining the best multivariable 
model was to examine the goodness-of-fit statistic. Good- 
ness of fit assessed the effectiveness of the model in 
describing the outcome variable. In addition, differences 
between the observed ata and the stimated values (the 
residual) for each covariate pattern were calculated by the 
Pearson or Hosmer-Lemeshow X 2 statistic. 9 The null 
hypothesis for goodness of fit claims that there are no 
significant differences between the predicted outcomes 
and the observed ata. Therefore a probability greater 
than 0.05 indicates acceptance of the null hypothesis and 
a valid model. 
The final approach to determining the best model for 
each outcome variable was to examine the receiver oper- 
ator characteristic (ROC) curve for each model. ROC 
curves are usually used to evaluate and compare an 
operator or diagnostic test with a "gold standard" and to 
explore the trade-offs between sensitivity and specificity 
for a test. a°' 11 Tests that discriminate well will crowd the 
curve toward the upper left corner. The overall accuracy 
of a test can be described as the area under the curve; 
increasing the area under the curve corresponds to a 
better test because it optimizes the sensitivity and speci- 
ficity.x2, 13 When calculated in the BMDP LR program 
(BMDP Statistical Software Inc., Los Angeles, Calif.), n 
the ROC curve is independent of both the cut-point 
criteria (predicted probabilities) and the prevalence of the 
outcomes. This independence allows comparison of the 
ROC area of different study populations where sensitivity 
and specificity would be distorted by differences in the 
prevalence of the outcomes of interest. Therefore we used 
these curves to provide an additional "diagnostic" tool to 
determine the optimum model for our binary outcome 
variables. 
The internal validity of the model was assessed by use of 
a bootstrap method in which the regression coefficients for 
the entire data set were correlated with the regression 
coefficients of a test data set. The test data set was derived 
as a subpopulation of the entire data set. 
Results 
The preoperat ive characteristics of the entire 
pat ient populat ion are l isted in Table I. The overall  
mortal i ty rate was 2.4% (n = 109). Low cardiac 
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output syndrome developed in 412 patients (9.1%). 
Table II compares the operative data for patients in
whom low cardiac output syndrome developed with 
data for those patients in whom it did not. Patients 
in whom low cardiac output syndrome developed 
were older (64 versus 61 years, p < 0.001) and had 
more extensive coronary artery disease (p < 0.001). 
There were no significant differences in the number 
of bypass grafts constructed between the two groups. 
Complete revascularization was accomplished in 
4193 (92%) patients. The operative mortality rate in 
patients in whom complete revascularization was 
achieved was 2.3% compared with 3.9% in patients 
in whom revascularization was not complete (p = 
0.068). The prevalence of low cardiac output syn- 
drome was 8.1% in patients in whom revasculariza- 
tion was complete versus 14.6% in patients in whom 
it was not (p < 0.001). 
The left anterior descending artery (LAD) terri- 
tory was revascularized in 99.6% of the patients with 
LAD disease. Similarly, the territories of the cir- 
cumflex and right coronary arteries were revascular- 
ized in 96.2% and 94.7% of the respective patients 
with disease in those territories. 
Patients in whom low cardiac output syndrome 
developed had longer cardiopulmonary bypass 
times, longer aortic crossclamp times, a longer post- 
operative intensive care unit stay, more days of 
ventilatory support, a longer hospital stay, and a 
higher postoperative CKMB level. Patients in whom 
low cardiac output syndrome developed had a 
higher mortality rate (17%) than patients in whom it 
did not develop (1%, p < 0.001). Patients in whom 
low cardiac output syndrome developed were more 
likely to have a perioperative MI (14.3% versus 
1.8%,p < 0.001). 
Predictors of low cardiac output syndrome. Figs. 
1 and 2 and Table III illustrate the univariate results 
for the multivariable predictors of low cardiac out- 
put syndrome. Stepwise logistic regression analyses 
identified nine independent predictors of postoper- 
ative low cardiac output syndrome (percentage in
whom low cardiac output syndrome developed in 
parentheses) and the factor-adjusted odds ratio 
(OR) associated with each predictor: (1) left ven- 
tricular ejection fraction less than 20% (27%, OR 
5.7); (2) repeat operation (25%, OR 4.4); (3) emer- 
gency operation (27%, OR 3.7); (4) female gender 
(16%, OR 2.5); (5) diabetes (13%, OR 1.6); (6) age 
older than 70 years (13%, OR 1.5); (7) left main 
coronary artery disease (12%, OR 1.4); (8) recent 
MI (16%, OR 1.4); and (9) triple-vessel disease 
Table II. Operative data 
P 
No LOS LOS Value 
No. of patients 4146 (91%) 412 (9%) 
Age (yr) 61.3 ± 9.6 63.6 ± 9.6 <0.001 
Diseased vessels 
1 286 (7%) 22 (5%) 0.0012 
2 1011 (24%) 72 (18%) 
3 2844 (69%) 315 (77%) 
Grafts 
1 72 (2%) 10 (2%) 0.660 
2 482 (12%) 51 (12%) 
3 1440 (35%) 138 (33%) 
4 1778 (43%) 177 (43%) 
5 374 (9%) 36 (9%) 
Pump time (min) 85 ± 24 110 ± 39 <0.001 
Crossclamp time 60 ± 18 67 ± 27 <0.001 
(rain) 
Days of ventilator 1.1 _+ 2.5 2.9 ± 5.0 <0.001 
support 
Days in ICU 2.2 -- 3.3 5.0 ± 6.3 <0.001 
Days in hospital 9.9 _+ 9.2 13.8 +- 12.4 <0.001 
CK (units) 897 _+ 769 1429 -+ 1309 <0.001 
CK-MB (units) 41 + 37 83 + 102 <0.001 
Percent CK-MB 5.9 ± 9.9 6.7 ± 6.4 <0.001 
Periop. MI 74 (1.8%) 59 (14.3%) <0.001 
Stroke 47 (1.1%) 14 (3.4%) <0.001 
Mortality 39 (0.9%) 70 (16.9%) <0.001 
LOS, Low cardiac output syndrome; ICU,, intensive care unit. 
(10%, OR 1.3). Table IV presents the regression 
coefficients, their standard errors derived from the 
logistic regression analysis, the ORs, the 95% con- 
fidence intervals (95% CIs) for the ORs, the im- 
provement X2 p value, and the goodness-of-fit p 
value for the nine independent predictors. The 
predictive probability of the development of low 
cardiac output syndrome can be calculated by the 
formula P = e~/(1 - e*), where x is the sum of the 
regression coefficients (see Appendix B). Fig. 3 
depicts the predicted probability of low cardiac 
output syndrome (abscissa) versus the logit score 
(ordinate) for several combinations of covariate 
patterns for low cardiac output syndrome. This 
figure can be used to determine the probability of 
low cardiac output syndrome for an individual pa- 
tient. 
There were 133 patients (2.9%) who had a peri- 
operative MI. The operative mortality rate was 
21.8% in this group of patients compared with 1.8% 
in patients who did not have an infarct. Patients with 
low cardiac output syndrome had a significantly 
higher prevalence of perioperative MI (14.3% ver- 
sus 1.8%, p < 0.001). Conversely, patients who had 
a perioperative MI had a 44% prevalence of low 
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Fig. 1. Univariate results of multivariable predictors of low cardiac output syndrome (LOS) and operative 
mortality (OM). Left ventricular grade (LV GRADE) designated by 1, ejection fraction 60%; 2, ejection 
fraction 40% to 59%; 3, ejection fraction 21% to 39%; or 4, ejection fraction 20%. Repeat operation 
(REDO), that is, previous aorta-coronary bypass, noted as yes (Y) or no (N). Timing of operation 
designated by 1, elective operation; 2, operation during same hospitalization as cardiac catheterization r
cardiac event (semielective); or3, urgent operation within 72 hours of cardiac event. Gender noted as male 
(M) or female (F). Diabetes; age younger than 70 years; and left main coronary artery disease (LEFT 
MAIN), that is, significant (greater than 50%) stenosis of left main coronary artery, noted as yes or no. 
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Fig. 2. Univariate results of multivariable predictors of low cardiac output syndrome (LOS) and operative 
mortality (OM). Recent MI, that is, MI within 30 days before operation; triple-vessel disease; and 
hypertension noted as yes (Y) or no (N). 
cardiac output syndrome compared with 8% in 
patients who did not have an infarct. 
Operative mortality. There were 109 operative 
deaths in this population. Among patients in whom 
low cardiac output syndrome developed (n = 412) 
there were 70 deaths (17%) compared with 39 
deaths (0.9%) in those in whom low cardiac output 
syndrome did not develop (n = 4146). The mean 
postoperative l ngth of stay for patients who died 
after the development of low cardiac output syn- 
drome was 7.4 _+ 11.3 days (median 3.5 days, range 
0 to 53 days). The mean postoperative length of stay 
for patients who died without having the develop- 
ment of low cardiac output syndrome was 23.1 ___ 
26.6 days (median 12.5 days, range 0 to 84 days). 
The operative mortality rate was significantly 
higher by univariate analysis in patients with a left 
ventricular ejection fraction less than 20% (10.9% 
versus 1.2% with left ventricular ejection fraction 
greater than 60%, p < 0.001); in patients undergo- 
ing repeat operation (7.5% versus 2.0%,p < 0.001); 
in patients with peripheral vascular disease (6.6% 
versus 1.8%, p < 0.001); in patients older than age 
70 (5.0% versus 1.1% in patients younger than age 
50, p < 0.001); in patients undergoing emergency 
operation (6.6% versus 1.7% in elective operation, 
p < 0.001); in patients with diabetes (3.8% versus 
2.0%, p = 0.001); in female patients (3.8% versus 
2.0%,p = 0.002); in patients with left main coronary 
artery disease (3.6% versus 2.1%, p = 0.014); in 
patients with hypertension (3.0% versus 1.8%, p = 
0.006); in patients who had an MI less than 30 days 
before operation (4.0% versus 2.1%,p = 0.002); in 
patients with chronic obstructive pulmonary disease 
(3.4% versus 2.2%, p = 0.036); and in patients with 
New York Heart Association class IV disease (3.6% 
versus 1.3% in New York Heart Association class I, 
p = 0.002). 
The multivariable predictors of operative mortal- 
ity were (1) left ventricular ejection fraction less 
than 20% (OR 8.1); (2) repeat operation (OR 4.9); 
(3) peripheral vascular disease (OR 2.8); (4) age 
older than 70 (OR 2.8); (5) emergency operation 
(OR 2.7); (6) diabetes (OR 1.7); (7) female gender 
(OR 1.7); (8) left main coronary artery stenosis (OR 
1.5); and (9) hypertension (OR 1.4). Table V pre- 
sents the regression coefficients, their standard er- 
rors derived from the logistic regression analysis, the 
ORs, the 95% CIs for the ORs, the improvement X 2
p value, and the goodness-of-fit p value for the nine 
independent predictors. The 95% CIs for left main 
coronary artery stenosis and hypertension both in- 
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Table III. Univariate analysis for low cardiac output syndrome and operative mortality 
LOS No LOS Mortality 
P Value p Value 
N % N % (LOS) N % (034) 
No. of patients 412 9 4146 91 
LVEF 
>60% 87 6 1443 94 <0.001 19 1 <0.001 
40%-60% 146 8 1780 92 44 2 
20%-40% 139 15 817 85 30 3 
<20% 40 27 106 73 16 11 
Repeat operation 82 25 253 75 <0.001 25 8 <0.001 
No Repeat 330 8 3893 92 84 2 
Timing <0.001 <0.001 
Elective 169 6 2451 94 45 2 
Semielective 112 10 1018 90 35 3 
Urgent 90 14 567 86 19 3 
Emergency 41 27 110 73 10 7 
Sex 
Male 271 7 3402 93 <0.001 75 2 0.002 
Female 141 16 744 84 34 4 
Diabetes 137 13 949 87 <0.001 41 4 0.001 
No diabetes 275 8 3197 92 68 2 
Age 
<70 283 8 3261 92 <0.001 58 2 <0.001 
->70 129 13 885 87 51 5 
Left main CAD 
Y 94 12 714 88 0.005 29 4 0.014 
N 318 9 3432 91 80 2 
Recent MI 
Y 112 16 580 84 <0.001 28 4 0.002 
N 300 8 3566 92 81 2 
Triple-vessel CAD 
Y 315 10 2759 90 0.002 80 3 0.651 
N 94 7 1391 93 29 2 
Hypertension 230 10 2107 90 0.053 70 3 0.006 
No hypertension 182 8 2039 92 39 2 
LOS, Low cardiac output syndrome; OM, 
operation; CAD, coronary artery disease. 
I 
operative mortality; LVEF, left ventricular ejection fraction; Y, yesN, no; recent MI, MI within 30 days before 
Table IV. Multivariable analysis for low cardiac output syndrome 
Regression Improvement GOF 
Variable coefficient SE OR 95% CI X 2 p value p value 
Constant -3,866 0.166 
LVEF 
40%-60% 0.1777 0.146 1.19 0.89-1.59 
20%-40% 0.8614 0.153 2.37 1.75-3.19 
<20% 1.7410 0.232 5.70 3.62-8.99 <0.001 0.031 
Repeat operation 1.4770 0.151 4.38 3.26-5.89 <0.001 0.277 
Timing of operation 
Urgent 0.2451 0.128 1,28 0.99-1.64 
Emergency 1.3120 0.237 3.72 2.34-5.91 <0.001 0.966 
Female gender 0.9287 0.122 2.53 1.99-3.22 <0.001 0.825 
Diabetes 0,4644 0.119 1.59 1.26-2.01 <0.001 0.983 
AGE ->70 0.3691 0.122 1.45 1.14-1.84 0.001 0.990 
Left main CAD 0,3500 0.133 1.42 1.09-1.84 0.011 0.993 
Recent MI 0.3241 0.148 1.38 1.04-1.85 0.023 0.994 
Triple-vessel disease 0.2841 0.130 1.33 1.03-1.71 0.026 0.996 
SE, Standard error; GOF, goodness of fit; LVEF, left ventricular ejection fraction; CAD, coronary artery disease; Rec nt MI; MI within 30 days before 
operation. 
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Fig. 3. Predictive probability of low cardiac output syndrome after coronary artery bypass grafting. Left 
ventricular grade (LV GRADE) scored from i to 4. Repeat aorta-coronary b pass (ACB REDO), diabetes, 
age older than 70 years, left main coronary artery disease (L MAIN DISEASE), recent MI, and triple-vessel 
disease (TVD) scored 0 for no, 1 for yes. M, Male; F, female; E, elective; S, semielective; U, urgent. 
Table V. Multivariable analysis for operative mortality 
Regression Improvement GOF 
Variable coefficient SE OR 95% CI X e p value p value 
Constant -5.760 0.316 
PVD 1.0330 0.215 2.81 1.84-4.28 <0.001 1.000 
LVEF 
40%-60% 0.4847 0.284 1.62 0.93-2.83 
20%-40% 0.7036 0.306 2.02 1.11-3.68 
<20% 2.0920 0.371 8 .10  3.91-16.80 <0.001 0.448 
Repeat operation 1.5810 0.251 4.86 2.97-7.95 <0.001 0.357 
Age >-70 1.0250 0.208 2.79 1.85-4.19 <0.001 0.439 
Female gender 0.5178 0.227 1.68 1.08-2.62 0.004 0.214 
Diabetes 0.5560 0.212 1.74 1.15-2.64 0.009 0.637 
Timing of operation 
Urgent 0.1317 0.217 1.14 0.75-1.75 
Emergency 0.9907 0.390 2.69 1.25-5.79 0.039 0.230 
Left main CAD 0.4341 0.232 1.54 0.98-2.43 0.059 0.660 
Hypertension 0.3542 0.212 1.43 0.94-2.16 0.091 0.682 
SE, Standard error; GOF, goodness offit; PVD, peripheral vascular disease; LVEF, left ventricular ejection fraction; CAD, coronary artery disease. 
clude unity, which indicates that they are weak 
predictors of operative mortality. 
Fig. 4 illustrates the predicted operative mortality 
for all combinations of the nine independent pre- 
dictors. Fig. 5 depicts the ROC curves for both low 
cardiac output syndrome and operative mortality. 
The area under the ROC curve for low cardiac 
output syndrome is similar to that for operative 
mortality (74% versus 76%), which indicates that 
both models are similar in terms of their sensitiv- 
ity and specificity to detect their respective out- 
comes. 
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Fig. 4. Predictive probability of operative mortality after coronary artery bypass grafting. Peripheral 
vascular disease (PVD), repeat aorto-coronary bypass (ACB REDO), age older than 70 years, diabetes, left 
main coronary artery disease (L MAIN DISEASE), and hypertension scored 0 for no, 1 for yes. Left 
ventricular grade (LV GRADE) scored from 1 to4. M, Male; F, female; E, elective; S, semielective; U, 
urgent. 
Discuss ion  
An increasing number of patients with high-risk 
conditions are undergoing coronary artery bypass 
grafting. 1 The extension of cardiac operation to 
patients at higher risk is a result of improved 
operative techniques and perioperative myocardial 
protection. Cardiologists and surgeons have ex- 
tended the benefits of coronary artery bypass to 
patients at higher risk as the risks of operation have 
decreased) 4 To continue to reduce perioperative 
morbidity and mortality, cardiac surgeons must de- 
vise strategies to improve myocardial protection in 
patients at high risk. 
Traditionally, the results of coronary artery by- 
pass have been evaluated by operative mortality and 
perioperative MI. 14-16 Low cardiac output syndrome 
is another clinical outcome that can be used to 
assess the efficacy of perioperative myocardial pro- 
tection. Two large randomized clinical trials failed 
to show any difference in perioperative mortality or 
MI between the treatment groups. 2' 3 The low rates 
of operative mortality and the problems inherent in 
uniformly defining and identifying perioperative in- 
farction have made the use of these outcome mea- 
sures impractical in modern studies of myocardial 
protection. 
For example, to detect a 20% reduction in the 
operative mortality rate from 2% to 1.6%, one 
would need to study 8504 patients to achieve a 5% 
level of significance with a power of 80%. To detect 
a 20% reduction in the prevalence of perioperative 
MI from 3% to 2.4%, one would require 5618 
patients. A similar 20% decrease in the prevalence 
of low cardiac output syndrome from 10% to 8% 
would require 1577 patients to achieve a5% level of 
significance. Patients in whom low cardiac output 
syndrome develop have a significantly higher prev- 
alence of perioperative MI and a higher operative 
mortality. Thus the development of low cardiac 
output syndrome represents either inadequate re- 
vascularization or inadequate myocardial protection 
and may act as a marker of intraoperative myocar- 
dial injury. Our results indicate that the territory 
supplied by the LAD was revascularized in more 
than 99% of patients with disease in that distribu- 
tion. Revascularization was incomplete in the terri- 
tory of the right coronary artery in 5% of the 
patients with right coronary artery disease. These 
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Fig. 5. ROC curves of predictive models forlow cardiac output syndrome (left) and operative mortality 
(right). 
patients likely represent a subpopulation with a 
previous inferior MI and an occluded coronary 
artery. Despite having preserved left ventricular 
function, these patients were still at risk for the 
development of postoperative low cardiac output 
syndrome. 
Diagnosis. A diagnosis of low cardiac output 
syndrome required the active intervention of the 
cardiac surgeon, and at our institution this interven- 
tion represented a failure of our usual perioperative 
strategy. Thus the diagnosis of low cardiac output 
syndrome was a reproducible clinical outcome. The 
Warm Heart Investigators established an indepen- 
dent committee to evaluate postoperative low car- 
diac output syndrome. 2 Their criteria for diagnosis 
were similar to ours and again support the concept 
that this syndrome can be used as an objective 
measurement of perioperative myocardial injury. 
This study identified nine independent preopera- 
tive predictors of low cardiac output syndrome after 
coronary artery bypass grafting (Figs. 1 and 2). The 
potential causes for inadequate postoperative car- 
diac performance are not well established. 
Poor ventricular function. Poor left ventricular 
function continues to be the most important predic- 
tor of postoperative morbidity and mortality. Pa- 
tients with poor ventricular function have a limited 
margin for myocardial protection. 16 However, the 
dysfunctional myocardium may not be irreversibly 
damaged and may be "stunned" or "hibernating." 
Revascularization of the reversibly injured heart 
may result in improved left ventricular performance. 
Cold injury or inhomogeneous cardioplegic delivery 
may exacerbate perioperative ischemic injury and 
result in inadequate arly postoperative ntricular 
function. 17 Prolonged reperfusion with a terminal 
"hot shot" of cardioplegic solution may restore 
function in patients with poor ventricular function, is 
Warm cardioplegia may improve postoperative l ft 
ventricular function in patients with high-risk con- 
ditions, inasmuch as we have previously shown that 
warm cardioplegia improves ventricular function in 
patients at low risk undergoing elective opera- 
tions. 17 Unfortunately, some patients will continue 
to have poor ventricular function after operation 
and the role of myocardial protection in these 
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patients may be to limit the extent of perioperative 
injury. 
Reoperation. Patients undergoing repeat opera- 
tions represent a challenge for intraoperative man- 
agement. Patients undergoing reoperation have 
more diffuse disease and are at risk of having a 
shower of emboli from their previous bypass grafts. 
The management of patent grafts is difficult. The 
study by Lytle and associates 19from the Cleveland 
Clinic revealed that the operative mortality rate in 
patients undergoing repeat coronary artery bypass 
was 4.3%. They found that patients with stenoses in 
vein grafts to the LAD region had decreased sur- 
vival. However, there were no in-hospital deaths 
among patients with totally occluded vein grafts or 
patent internal thoracic artery grafts to the LAD 
region. The authors speculated that the retrograde 
introduction of cardioplegic solution significantly 
lowered the operative mortality rate of repeat oper- 
ation as a direct consequence of reducing athero- 
sclerotic emboli from previous vein grafts. 19 
Urgent operation. Patients who require urgent 
operation because of unstable angina may benefit 
most from improved strategies of myocardial pro- 
tection. Prolonged preoperative ischemia may de- 
plete metabolic reserves. Substrate enhancement 
with Krebs cycle intermediates 2°'21 may benefit 
these patients. Rousou and associates 21showed that 
cardioplegic enhancement with Krebs cycle interme- 
diates such as glutamate, malate, succinate, and 
fumarate preserved high-energy phosphates during 
ischemic arrest but that this preservation did not 
extend to the reperfusion period. To date the effec- 
tiveness of substrate-enhanced ardioplegia remains 
controversial. The use of warm rather than cold 
cardioplegia may help to resuscitate the ischemic 
myocardium. Cold cardioplegia reduces myocardial 
oxygen consumption and lactate production, but 
delays the recovery of oxidative metabolism and 
ventricular function. Cold cardioplegia has the ad- 
vantage of improved protection to areas that are 
difficult to perfuse because of coronary obstructions. 
Warm cardioplegia may resuscitate the ischemic 
myocardium if it can be delivered uniformly and 
continuously. Discontinuation of normothermic 
blood cardioplegic solution delivery to permit visu- 
alization of the distal anastomosis may result in 
ischemic anaerobic metabolism. Perhaps the ideal 
cardioplegic temperature lies between the two ex- 
tremes. We have recently reported the use of "tep- 
id" (29 ° C) cardioplegia. 22Tepid cardioplegia re- 
duced lactate and acid production compared with 
warm (37 ° C) cardioplegia nd improved left ven- 
tricular function compared with cold (10 ° C) blood 
cardioplegia. 22
Female gender. The Coronary Artery Surgery 
Study investigators reported female gender to be 
associated with higher perioperative morbidity and 
mortality. 15 The authors postulated that this in- 
creased morbidity was a result of the smaller size of 
the coronary vessels and the higher risk of graft 
thrombosis. A recent review from our institution 22a 
revealed that female patients had a higher preva- 
lence of operative mortality and postoperative low 
cardiac output syndrome. The predictors of opera- 
tive mortality and postoperative low cardiac output 
syndrome were similar for both men and women. 
Small body size was an independent risk factor for 
postoperative morbidity. In patients of similar body 
size, female gender was an independent risk factor 
for low cardiac output syndrome and operative 
mortality. 
Diabetes mellitns. Patients with diabetes may 
have more diffuse atherosclerotic disease, which 
may limit complete revascularization. In addition, 
patients with diabetes may have silent ischemia nd 
be seen for operation after extensive MI or may 
have diffuse coronary artery disease. Cardioplegic 
protection may pose a problem in patients with 
diffuse coronary disease. Proximal coronary lesions 
may impair antegrade delivery of cardioplegic solu- 
tion and venovenous and thebesian shunting may 
reduce the retrograde delivery of cardioplegic solu- 
tion. Homogeneous distribution of cardioplegic 
solution may improve intraoperative myocardial 
protection in these patients. A recent study by 
Hayashida nd associates 23showed that a combina- 
tion of antegrade and retrograde cardioplegic solu- 
tion delivery may provide the best protection by 
improving the distribution of cardioplegic solution. 
Intermittent antegrade infusions after each period 
of continuous retrograde cardioplegic solution de- 
livery resulted in the washout of accumulated lac- 
tate. This finding suggested that the two directions 
of cardioplegic solution delivery perfuse different 
myocardial territories. Combining the two tech- 
niques may result in a more homogeneous distribu- 
tion of cardioplegic solution2 
Advanced age. Elderly patients continue to be at 
high risk for postoperative complications (Fig. 2). At 
our institution an i creasing proportion of patients 
older than age 70 are presenting for surgical treat- 
ment, but the prevalences of perioperative infarc- 
tion and operative mortality have decreased uring 
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the past decade. 24 The elderly are at increased risk 
not only because of the obvious effects of aging but 
also because of the increased prevalence of comor- 
bid conditions in this population. Misare, Kruken- 
kamp, and Levitsky 25 showed an age-dependent 
sensitivity to myocardial ischemia in an ovine model. 
These authors termed this phenomenon the senes- 
cent myocardium. Thus, independent of other co- 
morbid conditions, elderly patients may be at in- 
creased risk for perioperative myocardial injury 
because of their senescent myocardium. 
Left main coronary artery disease. The presence 
of left main coronary artery disease is no longer as 
important a predictor of operative mortality as it 
was previously. 1 Although left main stenosis was 
selected as an independent predictor of operative 
mortality, the confidence interval for the OR in- 
cludes one, which indicates that left main disease 
may not be a major predictor of operative mortality. 
However, in this study, left main coronary artery 
disease was still an independent risk factor for the 
development of low cardiac output syndrome. Im- 
provements in myocardial protection may have com- 
pensated for the increased risk in left main coronary 
artery disease. The use of retrograde or combination 
cardioplegic techniques may further educe the im- 
portance of left main disease on the outcome of low 
cardiac output syndrome. 
Recent MI and triple-vessel disease. Patients 
with an MI within 30 days of operation were at 
slightly higher risk for the development of low 
cardiac output syndrome. Similarly, patients with 
triple-vessel disease were at higher risk for the 
development of low cardiac output syndrome. Al- 
though both of these risk factors were selected as 
independent risk factors for the development of low 
cardiac output syndrome, the confidence interval of 
their ORs approached one. Thus, although statisti- 
cally significant, hese risk factors are weak predic- 
tors of low cardiac output syndrome. 
Hypertension and peripheral vascular disease. 
Hypertension and peripheral vascular disease 
were independent predictors of mortality but not 
of low cardiac output syndrome. These risk factors 
predispose patients to stroke and mortality may 
have been a result of noncardiac auses. There- 
fore these variables did not predict postoperative 
low cardiac output syndrome. Strategies to mini- 
mize the impact of these variables include im- 
proved management of perioperative blood pres- 
sure and minimal manipulation of the aorta 
during operation. The use of intraoperative ultra- 
sonography to detect atherosclerotic plaques to 
aid aortic cannulation has been advocated by 
Barzilai and colleagues. 26
Models. Fig. 3 illustrates the predictive probabil- 
ity of the development of low cardiac output syn- 
drome on the basis of data from our patient 
population. Fig. 4 illustrates the predictive prob- 
ability of operative mortality after aorta-coronary 
bypass. 
Greenland 27concluded that both stratified (pop- 
ulations tratified on the basis of risk) and modeling 
(predictive models derived from multivariable anal- 
yses) techniques to analyze populations have limita- 
tions based on the control of variable selection and 
the size and quality of data sets. Neither approach 
can compensate for fundamental methodologic er- 
rors such as misclassifications, selection bias, or lack 
of statistical power to address the questions of 
interest. Greenland 27 therefore concluded that 
more effort should be put into correctly interpreting 
and intelligibly presenting modeling results to re- 
flect these underlying errors. An evaluation of the 
ability of a model to correctly represent the under- 
lying data set is mandatory when presenting regres- 
sion analyses. The Pearson or Hosmer-Lemeshow 
statistics yield a measure of the goodness of fit for a 
particular model and can be used to compare mod- 
els derived from the same underlying data. The 
goodness-of-fit p values for our final models of low 
cardiac output syndrome and operative mortality 
were greater than 0.99 and 0.65, respectively, and 
suggested an excellent agreement between observed 
and predicted values. The internal validity of our 
models was evaluated with use of a bootstrap 
method. The regression coefficients between the 
whole data set and the test data set correlated for 
both operative mortality (r a = 0.981,p < 0.001) and 
low cardiac output syndrome (r2 = 0.987,p < 0.001). 
These results lend further support o the validity of 
these models. 
The ROC curves are another tool to evaluate the 
ability of a model to accurately represent the under- 
lying data. The advantage of the ROC curve is that 
it is independent of the prevalence of the outcome 
of interest and thus can be used to compare logistic 
models derived from different data sets with varying 
levels of incidence and prevalence. The areas under 
the ROC curve for the low cardiac output syndrome 
and operative mortality models were 74% and 76%, 
respectively (Fig. 5). These figures can be used to 
compare our logistic models with other models 
derived from a different patient population. The 
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larger the area under the ROC curve, the more 
accurate the model is in predicting outcomes in the 
underlying data set. With use of these objective 
criteria, one can determine whether differences in 
predictive models are true differences in the under- 
lying data or a result of inaccuracies in a poorly fit 
model. Similarly, these objective criteria can be used 
to compare models derived from different data sets 
and patient populations. Thus differences in predic- 
tive variables between patient populations can once 
again be ascribed to either true differences between 
the populations or to inaccuracies in poorly fit 
models. The use of such objective criteria will 
alleviate the problem of different multivariable 
equations arising from the same data set. 2s' 29 
This study presents the independent predictors of 
low cardiac output syndrome in 4558 consecutive 
patients who underwent isolated coronary artery 
bypass grafting at The Toronto Hospital. Our defi- 
nition of low cardiac output syndrome is objective 
and reproducible and can be used as an alternative 
clinical outcome of interest when the efficacy of new 
myocardial protective strategies i evaluated. 
We recognize the continued support of the cardiovas- 
cular surgeons at The Toronto Hospital: R. J. Baird, R. J. 
Cusimano, T. E. David, C. M. Feindel, I. H. Lipton, L. L. 
Mickleborough, C. M. Peniston, H. E. Scully, and R. D. 
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Appendixes 
Appendix A: Definitions of perioperative variables 
Elderly. Patients older than age 70 years. 
Diabetes. A preoperative diagnosis of diabetes mellitus 
treated with insulin, oral hypoglycemic agents, or diet. 
Triple-vessel disease. Critical lesions (greater than 50% 
luminal narrowing) affecting the territories upplied by 
the right, LAD, and left circumflex coronary arteries. 
Left main coronary artery disease. Greater than 50% 
stenosis of the left main coronary artery. 
Peripheral vascular disease. Known carotid, aortoiliac, or 
femoropopliteal disease or cases in which the patient had 
a previous carotid endartectomy or peripheral vascular 
operation. 
Transient ischemic attacks. A preoperative history of 
transient ischemic attacks, reversible ischemic neurologic 
deficits, or stroke. 
Normothermia. Systemic temperature higher than 35 ° C 
during cardiopulmonary b pass. 
Timing. Elective, same hospitalization, urgent (within 
72 hours of an event), or emergency (within 12 hours of an 
event). An event is either cardiac catheterization or an 
ischemic event after cardiac catheterization. Timing of 
operation is dependent on the symptomatic status of the 
patient. 
Recent MI. MI within 30 days before operation (Q wave 
or non-Q wave with an elevation of CK-MB level). 
Hypertension. Preoperative systemic hypertension e- 
cessitating medical treatment. 
Smoking. A history of smoking or current smoking. 
Left ventricular grade. Ejection fraction greater than 
60% (grade 1), ejection fraction between 40% and 60% 
(grade 2), ejection fraction between 20% and 40% (grade 
3), ejection fraction less than 20% (grade 4), as assessed 
by a single-plane contrast ventriculogram or by echocar- 
diography or nuclear ventriculography if a contrast ven- 
triculogram was not done. 
Appendix B. To calculate the predicted probability of 
low cardiac output syndrome or operative mortality for a 
given patient, start with the constant and then add the 
regression coefficients that describe the patient's charac- 
teristics for a coefficient total (x). Then use the formulap 
= e*/(1 + e~). For example, from Table IV the predicted 
probability of low cardiac output syndrome for a 72-year- 
old male patient with a left ventricular ejection fraction of 
35% and left main coronary artery disease but no diabe- 
tes, no previous coronary artery bypass grafting, and no 
recent MI undergoing urgent operation would be x = 
-3.866 + 0.3691 + 0.8614 + 0.350 + 0 + 0 + 0 + 0 + 
0.2451 - 2.0404; p = e2°4°4/(1 + e 2'°4°4) = 0.115 (or 
11.5%). 
